Aboxitin Injection

About Aboxitin 1 gm/vial Injection

Aboxitin 1 gm/vial is a injection product of Incepta Pharmaceuticals Ltd. that contains Cefoxitin. It belongs to the second-generation cephalosporin group of antibiotics.

There are 4 brands of Cefoxitin listed in Bangladesh.

What is Aboxitin 1 gm/vial Injection?

Aboxitin comes as a injection with 1 gm/vial of Cefoxitin, from Incepta Pharmaceuticals Ltd. Cefoxitin is used for certain serious infections caused by bacteria that are susceptible to it. Aboxitin 1 gm/vial is an injection form of Cefoxitin, a second-generation cephalosporin antibiotic. The dose and course are determined by the doctor based on the patient's condition.

Uses of Aboxitin

It belongs to the second-generation cephalosporin group of antibiotics. Not all infections respond to Cefoxitin; the doctor will decide if it is appropriate. Aboxitin is used to treat serious infections caused by bacteria that are susceptible to Cefoxitin. Ask your doctor whether it is right for your condition.

How to use Aboxitin

Aboxitin 1 gm/vial injection is given by a healthcare professional, usually by slow intravenous injection or infusion. Do not inject it yourself unless a doctor has shown you how. Do not attempt to use it yourself. Follow the healthcare team's instructions and tell them about any other medicines being taken, including those bought without a prescription. The doctor decides the dose, how often it is given and how long the course lasts, based on the infection and the person's condition.

Side effects of Aboxitin

If you notice any unusual symptoms during or after treatment, tell your doctor promptly. Ask the doctor or pharmacist about any side effect that worries you. Contact your doctor if you notice anything unusual after taking it. Tell your doctor if any side effect bothers you or does not go away.

Safety and precautions

Before receiving Aboxitin 1 gm/vial injection, tell your doctor if you are allergic to Cefoxitin, other cephalosporins, or penicillins, or if you have a history of colitis or seizure disorder. The doctor should also know about any kidney problems. Inform your doctor about any history of gastrointestinal disease, especially colitis, or seizure disorder. Your doctor will decide if it is suitable for you.

Frequently asked questions

What does Aboxitin treat?

It belongs to the second-generation cephalosporin group of antibiotics. Not all infections respond to Cefoxitin; the doctor will decide if it is appropriate.

How should I take Aboxitin?

Aboxitin 1 gm/vial injection is given by a healthcare professional, usually by slow intravenous injection or infusion. Do not inject it yourself unless a doctor has shown you how.

Can Aboxitin cause side effects?

If you notice any unusual symptoms during or after treatment, tell your doctor promptly. Ask the doctor or pharmacist about any side effect that worries you.

Who should be careful with Aboxitin?

Before receiving Aboxitin 1 gm/vial injection, tell your doctor if you are allergic to Cefoxitin, other cephalosporins, or penicillins, or if you have a history of colitis or seizure disorder. The doctor should also know about any kidney problems.

Indications

Cefoxitin is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below.

Lower respiratory tract infections, including pneumonia and lung abscess, caused by Streptococcus ... Read moreCefoxitin is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below.

Lower respiratory tract infections, including pneumonia and lung abscess, caused by Streptococcus pneumoniae, other streptococci (excluding enterococci, e.g., Enterococcus faecalis), Staphylococcus aureus(including penicillinaseproducing strains), Escherichia coli, Klebsiella species, Haemophilus influenzae, and Bacteroides species.

Urinary tract infections caused by Escherichia coli, Klebsiella species, Proteus mirabilis, Morganella morganii, Proteus vulgarisand Providencia species (including P. rettgeri).

Intra-abdominal infections, including peritonitis and intra-abdominal abscess, caused by Escherichia coli, Klebsiella species, Bacteroides species including Bacteroides fragilis, and Clostridium species.

Gynecological infections, including endometritis, pelvic cellulitis, and pelvic inflammatory disease caused by Escherichia coli, Neisseria gonorrhoeae (including penicillinase-producing strains), Bacteroides species including B. fragilis, Clostridium species, Peptococcus niger, Peptostreptococcus species, and Streptococcus agalactiae. Cefoxitin, like cephalosporins, has no activity against Chlamydia trachomatis. Therefore, when Cefoxitin is used in the treatment of patients with pelvic inflammatory disease and C. trachomatis is one of the suspected pathogens, appropriate anti-chlamydial coverage should be added.

Septicemia caused by Streptococcus pneumoniae, Staphylococcus aureus (including penicillinase-producing strains), Escherichia coli, Klebsiella species, and Bacteroides species including B. fragilis.

Bone and joint infections caused by Staphylococcus aureus (including Penicillinaseproducing strains).

Skin and skin structure infections caused by Staphylococcus aureus (including penicillinase-producing strains), Staphylococcus epidermidis, Streptococcus pyogenes and other streptococci (excluding enterococci e.g., Enterococcus faecalis), Escherichia coli, Proteus mirabilis, Klebsiella species, Bacteroides species includingB. fragilis, Clostridium species, Peptococcus niger, and Peptostreptococcus species.

Pharmacology

Cefoxitin inhibits bacterial cell wall synthesis by binding to 1 or more of the penicillin-binding proteins (PBPs) which in turn inhibit the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis and arresting cell wall assembly resulting in bacterial cell death.

Dosage & Administration

Intravenous:

Abdominal infections, Bone and joint infections, Gynaecological infections, Respiratory tract infections, Skin and skin structure infections, Urinary tract infections:
  • Adult: 1-2 g 6-8 hrly, up to 12 g daily given in 4-6 divided doses in severe infections. Doses are given by slow inj over 3-5 min or, by intermittent or continuous infusion.
  • Child: ≥3 mth 80-160 mg/kg daily in 4-6 equally divided doses. Max: 12 g daily.
Prophylaxis of surgical infections:
  • Adult: 2 g 30-60 min prior to surgery, then 6 hrly for not more than 24 hr. For caesarean section: 2 g as a single dose as soon as the umbilical cord is clamped; a further 2 g dose 4 hr and 8 hr after the initial dose may be given if necessary.
  • Child: ≥3 mth 30-40 mg/kg 30-60 min prior to surgery, then 6 hrly for not more than 24 hr.

Interaction

Reduces renal clearance with probenecid. Concurrent use of nephrotoxic agents (e.g. aminoglycosides, colistin, polymyxin B, vancomycin) may increase the risk of nephrotoxicity.

Contraindications

Hypersensitivity to cefoxitin and other cephalosporins.

Side Effects

Hypersensitivity reactions (e.g. maculopapular or erythematous rash, exfoliative dermatitis, pruritus, urticaria, eosinophilia, fever, angioedema); elevated serum creatinine and/or BUN concentrations, anaemia; transient increase in serum AST (SGOT), ALT (SGPT), LDH and alkaline phosphatase levels; jaundice; thrombophlebitis. Rarely, oliguria, renal toxicity, neutropenia, transient leucopenia, granulocytopenia, thrombocytopenia, bone marrow depression; GI effects (e.g. nausea, vomiting, diarrhoea).

Pregnancy & Lactation

Pregnancy Category B. Either animal-reproduction studies have not demonstrated a fetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters).

Precautions & Warnings

Patient with history of penicillin allergy, GI disease (particularly colitis) and seizure disorder. Renal impairment. Pregnancy and lactation.

Storage Conditions

Store between 2-25° C.

Alternative brands of Cefoxitin

Other brands with the same generic name, cheapest first.

Foxitane Injection

1 gm/vial

Cefoxitin

Advanced Chemical Industries PLC

Price not listed

Foxitane Injection

2 gm/vial

Cefoxitin

Advanced Chemical Industries PLC

Price not listed

Irva Injection

1 gm/vial

Cefoxitin

Square Pharmaceuticals PLC.

Price not listed

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.